kevindalby

 Originally published on prweb.com Dr.  Kevin Dalby , the principal investigator at the College of Pharmacy at the University of Texas at Austin, is one of six faculty members set to receive a recent grant to support ongoing, innovative cancer research. Recently, the Cancer Prevention and Research Institute awarded the six grants to UT faculty members as part of 73  grants they gave statewide that total more than $142 million. At the College of Pharmacy, Dr. Kevin Dalby is leading the investigation that will use the CPRIT award toward the Targeted Therapeutic Drug Discovery and Development Program. The goal of this particular program is to use new and integrated approaches to targeted molecular drug discovery. By doing this, it will increase the number of new compounds in the state of Texas that process needed qualities to eventually inhibit growth targets in tumors. Many researchers in the field of cancer have identified critically important targets related to cancer. Ho...

  Originally published on   agreensign.com Did you know: Viruses are the cause of a large number of cancerous tumors. This alarming fact is the reason for the urgency behind the research scientists are pursuing concerning treatments of such virus sparked cancers. Immunotherapy is one of the promising treatment choices used to treat a different variety of tumors. Kevin Dalby, Austin -based scientist, working on cancer drug discovery, is currently studying the mechanisms of cancer cell signaling to develop targeted therapeutics. Through his research, Dalby is familiar with the use of checkpoint inhibitors as immunotherapy agents for virus-related cancers. Dalby goes into some detail on how checkpoint inhibitors are used in combination with individualized precision medicine for the treatment of virus-related cancers. Comprehending Immunotherapy A type of cancer treatment that assists in enhancing the  body’s natural defense  to battle cancer is known as immunotherapy. T...

Originally published on  personal-development.com There is more to March besides dusting off that outfit of green for St. Patrick’s Day. March is also Colorectal Cancer Awareness Month. Spreading the awareness of colorectal cancer is essential, especially since its month of awareness is not widely known. Dr. Kevin Dalby , professor at The University of Texas at Austin, is one of the dedicated scientists working towards cancer drug discovery. Though the future of cancer treatments holds hope, Dalby expresses the importance of education and awareness of cancer types such as colorectal cancer and how taking the appropriate steps can save lives. What is Colorectal Cancer? Colorectal cancer is cancer found in the  colon or rectum . It is the third most common cancer found in both men and women in the United States, with more than  145,600 people  predicted to undergo diagnosis this year. Also, colorectal cancer lies in second place for cancer-caused dea...